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Abstract. Cell-matrix  interactions are assumed to be 
important in regulating differentiation and tumor cell 
growth; however, the precise roles of individual matrix 
receptors in producing cellular responses are still  un- 
clear.  We have previously described the etv/~6 integrin, 
an epithelial cell fibronectin receptor expressed in 
many carcinoma cell lines.  Here we show that heterol- 
ogous expression of otv/$6 in a human colon carcinoma 
cell line (SW480) enhances the proliferative capacity 
of these cells, both in vitro and in vivo in nude mice. 
This property of av86 correlates with the presence of 
an  ll-amino acid region at the COOH terminus  of the 
B6 cytoplasmic domain.  This  ll-amino acid sequence 
is required for the growth stimulatory effect, but not 
for other functions of the/36 cytoplasmic domain, 
such as promoting cell adhesion and focal contact 
localization. 
I 
NTEGRINS are  heterodimeric  cell  adhesion  receptors 
composed of two subunits (tx and/~), both of which con- 
tain a large extraceUular domain, a transmembrane do- 
main  and  a  short,  COOH-terminal  cytoplasmic  domain 
(Hynes, 1992). At least 20 different integrins  are known to 
interact  with a variety  of extracellular  matrix  components, 
including  fibronectin,  vitronectin,  collagens,  and laminins. 
Integrins have been shown to influence a wide array of cellu- 
lar functions, presumably as a result of interactions  between 
their cytoplasmic domains and intracellular  signaling mole- 
cules. 
The B subunit cytoplasmic domain is required for linking 
integrins to the cytoskeleton (Hynes, 1992). In many cases, 
this  linkage  is  reflected  in  localization  to  focal  contacts, 
which is believed to lead to the assembly of signaling com- 
plexes that include  ct-actinin,  talin, and the focal adhesion 
kinase (pp125-FAK) (Guan and Shalloway, 1992; Kornberg 
et al.,  1992;  Otey et al.,  1990).  At least three  different 
regions (Reszka et al., 1992) that are required for focal con- 
tact localization  of B1 integrins have been delineated.  These 
regions  contain conserved sequences that are also found in 
the cytoplasmic domains of the 82, B3, 85, 86, and 87 inte- 
grin subunits. The functional differences between these cyto- 
plasmic domains with regard to their signaling capacity have 
not yet been established. 
The t~v86 integrin is a fibronectin receptor expressed pre- 
dominantly  by  epithelial  cells  (Breuss  et  al.,  1993).  In 
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healthy  adult primate  tissues,  B6 mRNA and protein  are 
rarely detected (Breuss et al., 1993, and unpublished data). 
In contrast, B6 is expressed during fetal development, wound 
healing,  and in a variety  of epithelial  tumors (unpublished 
data). These observations suggested a possible distinct  role 
for this receptor in epithelial cell migration  or proliferation. 
In the present study, we heterologously expressed the 86 
subunit in a colon carcinoma cell line, SW480, from which 
it is normally absent, and examined the effects of txv~6 on 
a  number  of aspects of cell behavior.  Expression of this 
receptor conferred on these cells an enhanced  capacity to 
proliferate.  By performing similar experiments with a series 
of cytoplasmic domain truncation  mutants,  we identified an 
l 1-amino  acid COOH-terminal  region,  unique to the/36 
subunit,  that is required for the proliferation-enhancing  ac- 
tivity of the otvB6 integrin. 
Materials and Methods 
Antibodies and Reagents 
Monoclonai antibodies, ETP6 and R6Gg, directed to the extracellular do- 
main of human/36, were prepared and characterized in our laboratory, as 
previously described (Weinacker et al., 1994).  Monoclonai antibody L230 
against txv integrins was prepared in our laboratory from hybridoma cells 
obtained  from  the  Amer.  Type  Culture  Collection  (Rockville,  MD) 
(Weinacker et al.,  1994).  Monoclonal antibodies P1H5  against ~x2, and 
P3D10 against c~5 were gifts from Elizabeth Wayner (University of Min- 
nesota, Minneapolis, MN). Antibodies FIB5, against ~x3, and JIB5, against 
tx6, were obtained from Telios (San Diego, CA), and antibody 9G2 against 
/33 was a gift from Jin Kim (Genentech, South San Francisco, CA). Mono- 
clonai antibody to vinculin was obtained from Sigma Chem. Co. (St. Louis, 
MO). Biotinylated sheep anti-mouse IgG and streptavidin-fluorescein  were 
obtained from Amersham Corp. (Arlington Heights, IL). Enzymes BstEII, 
XbaI, NotI, and XhoI were purchased from Promega Corp. (Madison, WI). 
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chased from Sigma Chem. Co. Fibronectin and vitronectin was prepared 
from human plasma as described (Engvall and Ruoslahti, 1977; Yatohgo et 
ai.,  1988).  Cells were grown in DMEM supplemented with 4.5 gm/liter 
glucose, L-glntamine, 10% FBS and penicillin/streptomycin, unless stated 
otherwise. 
Preparation of Expression Plasmids 
A cDNA containing the entire coding region of human/~6 in the mammalian 
expression vector pcDNAIneo (Invitrogen, San Diego, CA) was constructed 
as previously described (Weinacker et al.,  1994).  To construct truncated 
versions of pcDNAIneo/36 that lacked selected portions of the cytoplasmic 
domain,  cDNA  fragments were amplified by PCR  using a  5' upstream 
primer corresponding to nt 2050-2070 and 3' downstream primers at the fol- 
lowing positions: (/) nt 2534-2557 to prepare pcDNAIneo/~6(777t);  (2) nt 
2516-2536 to prepare pcDNAIneo/36(770t);  (3)  nt 2447-2467  to prepare 
pcDNAIneoB6(747t);  and (4) nt 2417-2440  to prepare pcDNAIneo/36(738t). 
The full-length plasmid, pcDNAIneoB6, was used as a template. The 3' 
primers introduced stop codons to replace amino acids E778,  N771,  E748, 
and R739, respectively, and each primer included an XbaI recognition se- 
quence to facilitate ligation into the unique XbaI site in the pcDNAIneo 
polylinker.  Each PCR fragment included a  unique BstEII site in/36 (nt 
2087). The PCR products were digested with Xbal and BstEII and ligated 
into pcDNAIneo~6 that had been digested with the same enzymes (Cone 
et al.,  1994).  The authenticity of each mutant clone was confirmed by 
dideoxy sequencing using Sequenase 2.0 (Un. States Biochemical Corp., 
Cleveland, OH). 
Transfection of  Mammalian Cells 
SW480 colon carcinoma cells obtained from the Amer. Type Culture Col- 
lection and the adenovirus-transformed human embryonic kidney cell line 
293  (obtained  from  Sarah  Bodary,  Genentech)  were  transfected  with 
pcDNAIneo constructs containing wild-type or mutant forms of human ~6, 
or the expression plasmid only (pcDNAIneo) by the calcium phosphate 
precipitation method in which the calcium phosphate/DNA precipitates 
were added to 106 suspended cells that had been removed from tissue cul- 
ture dishes by trypsinization (Sambrook et ai.,  1989).  After transfection, 
the cells were grown for two days in their usual medium, and then transfec- 
tants were selected by growth in the same medium supplemented with the 
neomycin analog, G418. Individual transfected clones were prepared by lim- 
iting dilution cloning in 96-well plates. Stably transfected cells were further 
cotransfected with expression plasmids containing cDNA encoding firefly 
luciferase (pRKluc) and a similar plasmid containing a hygromycin resis- 
tance gene (pRKhyg) (Crowley et ai., 1993), and transfectants were selected 
by growth in both G418  and hygromycin, pRKluc and pRKhyg were girls 
from Robert Cohen (University of California, San Francisco, CA). Trans- 
fected clones were analyzed with a Luciferase Assay System (Promega), and 
light intensity was measured with a  scintillation counter (Nguyen et al., 
1988) (LS 5000, Beckmann, Mountain View, CA). The luciferase activity 
per cell of mock, full-length #6, and truncated/~6 transfectants selected for 
use in in rive experiments did not differ by more than 6 %. Luciferase activ- 
ity of each clone was measured on at least two occasions at least three 
months apart, and remained essentially constant over that time period. 
Fluorescence-activated Cell Sorting 
/~6-transfected cells were sorted by flow cytometry in the following manner: 
Transfected cells were allowed to grow in selection medium to •60-80% 
confluence in 100-mm tissue culture plates. The cells were then harvested 
by trypsinization and blocked with normal goat serum at 4°C for 10 rain. 
Cells were washed once with PBS, incubated with primary antibody E7P6 
for 20 rain at 4°C, and then washed twice with PBS. Cells were then stained 
with secondary antibody conjugated with phycoerythrin (Boehringer Marm- 
helm, Indianapolis, IN) for 20 rain at 4"C, washed twice with PBS, and 
resuspended in 0.5 ml of PBS with 5 % normal goat serum. The stained cells 
were sorted using FACS 440 (Becton Dickinson, Rutherford, NJ). The cells 
in the upper tenth percentile of fluorescence intensity were collected and 
grown in selection medium. Sorted transfectants were periodically analyzed 
for t~v/~6 expression using the labeling method described above and com- 
parison and fluorescence intensity with wild-type SW480 ceils as negative 
control using FACScan (Becton Dickinson).  Expression of the integrin 
subunits a2, a3, c~5, ct6,/31,/~3, and t5 was also analyzed for selected 
transfectants using monoclonal antibodies P1H5, P1B5, P3D10, J1B5, P5D2, 
9(32,  and PIF6, respectively. 
Cell Proliferation Assays 
Bilayer collagen gels comprising a 500-/~1 cell-free underlayer and a 500-/zl 
upper cell-containing layer were prepared in 24-well tissue culture plates. 
Cell-free base layers consisted of equal volumes of collagen type I (Sigma, 
3.0 mg/mi in 40 mM acetic acid) and a 2x  concentrate DMEM without 
FCS. The pH of the mixture was adjusted to 7.4 by addition of I M sodium 
hydroxide and the collagen-medium mix then supplemented with 5 % FCS. 
For the upper collagen layer, harvested cells suspended in FCS were added 
to the collagen-medium mix. After gelation, 500 ~1 of  culture medium (con- 
taining 5 % FCS) were added to each well. In all experiments, triplicate gels 
were prepared containing 104 cells and incubated at 37°C in 5% CO2 for 
7 d. At the termination of experiments, the collagen matrix was dissolved 
with collagenase (Sigma Chem. Co., Cat. No. C5138,  15 mg/rnl in PBS) 
and total cell number per well estimated by counting cells in a hemocytome- 
ter. For antibody inhibition experiments, antibodies were added directly to 
the collagen medium mix before gelation, and were added to the overlying 
culture medium 4 d after gelation. 
To analyze proliferation in standard culture dishes, 6-well plates were 
coated with  fibronectin (10  #g/ml)  or collagen I  (10  /~g/ml),  and  then 
blocked with  1% BSA. Cells plated in duplicate at a density of 5  x  103 
cells/well,  were  allowed  to  proliferate  in  DMEM  supplemented with 
selenium (5 ng/ml), hydrocortisone (1/Lg/mi),  insulin (5/~g/rni),  transferrin 
(5/~g/ml), and nonessential amino acids (ICN Biomedicais, Irvine, CA), 
in the presence or absence of 5 % FCS. On days 1 and 3 after plating, dupli- 
cate wells were labeled with [3H]thymidine for 4  h,  cells were washed 
twice with cold PBS, and incorporated label was precipitated with 15% 
TCA.  Precipitates were washed twice with cold 70%  ethanol to remove 
unincorporated label, resuspended in  I  M  NaOH,  and neutralized with 
1 M HC1. Thymidine incorporation was quantified by scintillation counting 
(Beckmann LS5000).  In parallel triplicate wells, cells were removed and 
counted at each time point without labeling. 
Cell Adhesion Assays 
Cell adhesion assays were performed as previously described (Busk et ai., 
1992).  Briefly, wells of non-tissue culture-treated polystyrene 96-well flat- 
bottom microtiter plates (Linbro/Titertek,  Flow Laboratories,  McLean, 
VA) were coated with various concentrations of fibronectin, vitronectin, or 
type I collagen, washed with PBS, and then blocked with 1% BSA in serum- 
free DMEM.  Cells were incubated in the presence or absence of the ~1 
blocking antibody P5D2 for 15 min at 4°C and were then plated onto the 
microtiter plates at a density of 50,000 cells/well in 200 t~l of serum-free 
DMEM containing 0.05 % BSA. The plates were centrifuged (top side up) 
at 10 g for 5 min, and then incubated for one hour at 37°C in humidified 
5 %  CO2.  Non-adherent cells were removed by  centrifugation top side 
down at 48 g for 5 rain. The attached cells were fixed with 1% formaldehyde 
and stained with 0.5% crystal violet, and then the wells were washed with 
PBS. The relative number of cells in each well was evaluated by measuring 
the absorbance at 595 run in a Microplate Reader (Bio-Rad Labs., Hercules, 
CA). The data were expressed as the mean of the absorbance of triplicate 
wells. Measurements of absorbance were determined to be linearly related 
to input cell number over the range of 10,000-50,000 cells/well. 
Immunofluorescent Localization 
Cells were harvested by trypsinization  before reaching 75 % confluence. 1-3 
x  104 cells were plated onto sterile acid-washed 12-mm-diarn glass cover- 
slips that were coated with fibronectin (10 #g/ml) and blocked with 1% BSA 
in PBS. Coverslips were incubated for 4 h at 37°C in 5% COz. Ceils were 
rinsed briefly in PBS, fixed with 2 % paraformaldehyde (Fisher Scientific, 
Pittsburgh, PA) in PBS (pH 7.4) for 10 rain, incubated for 20 rain in 0.1% 
Triton X-100 in PBS, and processed for immunofluorescence microscopy 
as follows: cell monolayers were blocked for 20 rain in 1% BSA. Ceils were 
incubated for 60  min in primary antibody; and then for 30  rain in bi- 
otinylated  sheep  anti-mouse  IgG  (1:50);  and  finally  for  30  min  in 
streptavidin-fluorescein (1:100). Coverslips were briefly rinsed in distilled 
water and mounted on microscope slides using Fluoromount G  (Fisher 
Scientific). 
Tumor Growth and Metastasis In Vivo 
Lucifernse-transfected  SW480 cells in log phase growth were removed from 
tissue culture plates with 0.05 % trypsirdEDTA, and cell counts and viability 
were  assessed  by  counting  cells  stained  with  0.4%  trypan  blue  in  a 
hemocytometer. Only cell preparations demonstrating greater than 95 % 
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in BSS, and either 10  ~ or 5 x  106 cells in 50 ttl were injected through a 
27-gauge needle into the subcutaneous region  of the right flank of 8-wk-old 
Balb C/nude athymic  male mice (Simonsen, S., San Francisco, CA). In ad- 
ditional experiments, tumor cells were either injected directly into the 
spleen, or into the wall of  the cecum. Primary tumors, as well as liver, lung, 
heart, cecum, brain, and femur  were removed  after either 6 wk (for animals 
injected with 5 x  106 cells) or 9 wk (for animals injected with 106 cells). 
The samples were frozen  in liquid nitrogen, and the entire tissue was pulver- 
ized with a Bessmer  tissue pulverizer (Fisher Scientific), and then incubated 
with 1 ml of Luciferase Assay  lysis buffer (Promega) for one hour at room 
temperature. Lysates were centrifuged at 13,000 rpm for 20 min, 10 td of 
supernatant was added to 100 ~1 of luciferin substrate, and luminescence 
was measured immediately in a luminometer (model 20e, Turner Designs, 
Sunnyvale, CA) equipped with a 0.25% neutral gray filter. Luciferase  activ- 
ity was determined to be linearly related to cell number over the range of 
103-10  s cells/assay using this technique. 
Results 
Effects of[36 Expression on Proliferation 
in Collagen Gels 
To examine the effects of otv/~6 on epithelial  cell behavior, 
we stably transfected the human colon carcinoma cell line, 
SW480,  with  full-length  /~6  eDNA.  We  have  previously 
reported that transfection of these cells with/~6 alone results 
in surface expression of otv~6 and increased capacity to at- 
tach to fibronectin-coated culture dishes (Weinacker et al., 
1994).  Wild-type SW480 cells migrate poorly on fibronec- 
tin, and efficiently form colonies in soft agar. These proper- 
ties were not affected by heterologous expression  of t~v/36 
(data not shown). However, in a three-dimensional collagen 
gel,  non-transfected  or vector only transfected  cells  grew 
poorly, whereas/36-transfected cells formed large branching 
colonies (Fig.  I  a).  This difference in colony morphology 
was accompanied by a significant difference in cell number. 
To confirm that this proliferative effect was a  direct conse- 
quence of/~6 expression, and not simply a function of clonal 
variation,  we repeated  these  experiments  with  a  series  of 
mock and/~6-transfected clones.  A  total of 14 clones were 
established  (five mock and nine  B6 transfectants)  and en- 
hanced in vitro growth was observed for all nine/~6 clones 
tested compared with the five mock-transfected clones (Fig. 
1 b).  Incorporation of the anti-ore blocking antibody L230 
(Weinacker et al.,  1994) into the collagen gel had no effect 
on the proliferation  of mock-transfected SW480 cells,  but 
abolished the increase in proliferation in/36-transfected cells 
(Fig.  1  c),  providing  further  evidence  that  the  increased 
proliferation of t6 transfectants was a direct result of t~v/36 
expression. 
The nine/~6-transfected clones expressed similar amounts 
of t6 on their surface (expression varied by only threefold 
based  on  mean  fluorescence  intensity  determined  by  flu- 
orescence-activated  cell  analysis).  /~6  expression  in  these 
transfectants was similar to the level we have previously de- 
scribed for native expression in the pancreatic carcinoma cell 
line FG (Weinacker et al.,  1994). Over this narrow range of 
expression,  we were unable to detect any quantitative rela- 
tionship between the level of B6 expression and the magni- 
tude of the proliferative response. To determine whether het- 
erologous expression of/~6 affected the expression of other 
integrin subunits, we analyzed surface expression of ct 2, o~3, 
or5,  tx6,  El,/33,  B5,  and B8  in  three  mock and  three  B6- 
transfected clones by fluorescence-activated cell analysis. As 
Figure 1. Effect of B6 transfection  on the ability of SW480 ceils to 
proliferate within three-dimensional  collagen type I gels.  (a) Pho- 
tomicrograph of mock and full-length/56  transfectants  after 7 d in 
collagen gels. (b) Total cell counts for each of five mock clones and 
nine full-length/56 clones.  Cells  were removed from the gel by 
treatment  with collagenase and counted in a hemocytometer. Bars 
to the right of each set of individual  data points describe the mean 
+  standard error. (c) Effect of  blocking antibody against c~v (L230) 
on total cell counts of mock and Bt-transfected cells allowed  to 
proliferate  for 7 d in collagen gels. The non-blocking anti-/56 anti- 
body, RtGg, was used as a control (Weinacker et al., 1994). Shaded 
bars represent mean values of triplicate  wells and lines above each 
bar represent the standard error of  the mean. The results shown are 
representative  of three similar experiment  s . 
Agrez et al. ctv~6  Induced Proliferation  549 Table L Expression of Various Integrin Subunits (as Measured by Mean Fluorescence Intensity Using FACS) of 
Mock- and/$-transfected SW480 Clones 
~2  a3  ~5  a6  ~1  B3  B5  ~6 
MOCK 
C2  420  1301  187  159  1596  9  410  6 
F3  517  1196  450  446  1928  9  961  9 
F11  512  1229  274  407  1487  9  924  8 
SW/~6 
C7  700  910  353  353  1775  10  483  318 
B2  511  910  290  290  1540  15  411  196 
G2  440  1684  638  638  2073  11  412  522 
shown in Table I, there was some clonal variation in expres- 
sion of other integrins among transfected SW480 cell clones, 
but no consistent difference in expression of or2, or3, or5, or6, 
or fl 1. None of the clones expressed significant amounts of 
/$3. There was a tendency for lower expression of/~5 in ~6- 
transfected clones, perhaps reflecting competition for endog- 
enous tav. This effect is not likely to explain the observed 
differences in proliferation, however, since mock clone C2 
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C 
Fibronectin  Collagen 
~:)  li]  v"  /  ¢~0  lilv.- 
X  12  X  12 
'i  :3  i  3 
1 
%  12  %  12 
't~  v- 
u 
1  3  i 
%  o  T- 
X  1  X  1 
-E  -E 
T  o,  ~o' 
Days 
1  3 
Days 
Figure 2. Proliferation of mock-(e) and/~6-(D) transfected SW480 
cells in culture dishes coated with collagen or fibronectin. Cells 
were plated in the absence of serum (a and b) or in the presence 
of 5% FCS (c) on 6-well plates coated with  10 #g/ml of either 
fibronectin (left column) or type I collagen (right column) and har- 
vested 1 or 3 d after plating, a and c show mean (+ standard error) 
data for cell counts from duplicate wells of three separate clones 
of each transfectant at each time point, and b shows mean (+ stan- 
dard error) values for [3H]thymidine incorporation. 
expressed the same level of/$5 as the three/$6 transfectants 
studied, but did not exhibit enhanced proliferation. 
Effects of[36 Expression on Cell Proliferation 
in Two-Dimensional Culture 
To determine  whether the  enhanced  proliferation of/$6- 
transfected SW480 cells in collagen gels required a  three- 
dimensional culture system, we examined the proliferation 
of three mock- and three/$6-transfected clones in standard 
tissue culture dishes coated with either fibronectin or colla- 
gen. Because proliferation in collagen gels required the pres- 
ence of 5 % FCS, we performed these assays in the presence 
or absence of serum.  As shown in Fig.  2, mock- and/$6- 
transfected cells proliferated equally well on both substrates 
in the presence or absence of serum.  Thus, the enhanced 
proliferation of/$6-transfected SW480 cells appears to re- 
quire a three-dimensional culture system. 
Effects of Cytoplasmic Domain Deletions on 
~6-mediated Proliferation  in Collagen Gels 
The effect of/$6  expression on  SW480  cell proliferation 
raises the question of which structural feature(s) of the oce/$6 
receptor are responsible for this effect. The most obvious 
candidate is the/$6 cytoplasmic domain, which is likely to 
be involved in transmitting any signals unique to/36. Com- 
parison of the/$6 cytoplasmic domain to the well-character- 
ized cytoplasmic domains of/$1 and t3 reveals that the/$6 
cytoplasmic domain contains sequences that are known to be 
required for focal contact localization (overlined in Fig. 3 a). 
In  addition,  the  /$6 cytoplasmic domain contains  an  l 1- 
amino acid COOH-terminal extension that is unrelated to se- 
quences found in other integrins.  We speculated that this 
ll-amino acid extension might be necessary for the prolif- 
eration-stimulating effects of ~6. To test this hypothesis, we 
generated stably transfected SW480 cells expressing a trun- 
cated/$6 construct lacking these 11 amino acids. Three addi- 
tional mutants with more extensive cytoplasmic domain de- 
letions  were  also  tested.  Each  of the  mutants  was  well 
expressed on the cell surface as shown by surface staining 
with the anti-c~vfl6 antibody E7P6 (Fig. 3 b). Heterologous 
expression of these mutant versions of/$6, like expression of 
the full-length version, did not produce any systematic alter- 
ation in the expression of other integrins (Table II). As shown 
in Fig. 4 a, deletion of the  11-amino acid extension com- 
pletely abolished the ability of/$6 to promote SW480 cell 
proliferation in collagen gels. As expected, more extensive 
or complete deletion of the/$6 cytoplasmic domain similarly 
abolished fl6-enhanced proliferation. 
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Figure 3. (a) Alignment of the cytoplasmic domains of the integrin 
/3 subunits, /31, /32, f13, and t6 using the one letter amino acid code. 
Dashed lines above the sequences mark the three highly conserved 
regions (R/, R2, and R3) identified as important for localization of 
the/31 subunit to focal contacts (Reszka et ai., 1992). The I 1-amino 
acid  COOH-terminal  extension  in  /36  is  underlined.  (b)  Flow 
cytometry analysis of SW480 cells transfected  with truncated ver- 
sions of the human t6 cytoplasmic domain. White peaks represent 
unstained cells. Black peaks represent  ceils transfected  with the/36 
truncations.  The extent of  the COOH-terminal truncations is shown 
schematically to the right of each graph. Values for mean fluores- 
cence intensity  (MFI) are shown above and to the right of each 
histogram. 
Effects of Cytoplasmic Domain Deletions 
on ~vfl6-mediated Cell Adhesion and on t6 
Localization to Focal Contacts 
The effects of cytoplasmic domain deletions on cell prolifer- 
ation suggest that the 11-amino acid extension of/% could 
a 
b 
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¢J 
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Mock  136  738t  747t  770t  777t 
Figure 4. Effect of/36 cytoplasmic domain deletions  on the ability 
of SW480  ceils  to proliferate  within  three-dimensional  collagen 
type I gels (a), and on cell adhesion to fibronectin (b). (a) Triplicate 
gels  were seeded  with  104 cells  for each of the transfectants  and 
the gels dissolved seven days later with collagenase before estimat- 
ing cell number in a hemocytometer. Shaded bars represent  mean 
values from triplicate wells and lines above each bar represent  stan- 
dard errors.  The data shown are representative  of three similar ex- 
periments.  (b) Mock- and fl6-transfected  SW480 cells  (full-length 
/36 and deletion mutants) were allowed to adhere to individual wells 
of 96-well microtiter plates which had been coated with fibronectin 
(3 ~g/ml).  5  x  104 cells were seeded in the presence of/31 block- 
ing antibody P5D2. Non-adherent cells were removed by centrifu- 
gation and the attached cells stained with crystal violet (Weinacker 
et al.,  1994). Cell adhesion was quantitated  by measuring the ab- 
sorbance at 595 nm in a Microplate Reader. The data shown repre- 
sent mean (+  standard  error) values from triplicate  wells  from a 
single experiment. 
be responsible for transmitting a proliferative signal unique 
to fl6. However, an alternative explanation would be that the 
11-amino acid extension is required for the overall function 
of the cytoplasmic domain. To test this possibility, we ana- 
lyzed the ability of the deletion  mutants  to perform other 
known  functions  of/36,  i.e.,  promotion  of adhesion  to 
fibronectin and localization to focal contacts.  Removal of 
the 11-amino acid extension did not abolish the ability of t6 
to promote adhesion to fibronectin, whereas more extensive 
deletions did (Fig. 4 b). Transfectants expressing the recep- 
tor missing the COOH-terminal  11  amino acids were also 
Table IL  Expression  of Various Integrin  Subunits  (as Measured  by Mean Fluorescence  Intensity  Using FACS) of 
SW480 Cells Transfected with Full-Length  and Various Truncated/36 
a2  a3  a5  u6  fll  t3  f15  f16 
SWfl6  540  1367  689  483  2191  7  732  359 
738t  479  2158  326  300  2013  18  928  745 
747t  605  1436  261  244  1846  23  594  1062 
770t  348  1442  200  177  1664  10  207  251 
777t  502  1677  269  246  1747  10  899  548 
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plasmic domain deletions  on 
immunolocaiization of the B6 
subunit.  Vinculin  localization 
within  focal  adhesions  is 
shown in a-d for (a) mock, (b) 
full-length  /~6, (c)  770t,  and 
(d) 777t. Localization of/~6 to 
focal adhesions  was seen only 
for  full-length  /56  and  the 
receptor lacking the I 1-amino 
acid  COOH-terminai  exten- 
sion (7770  (f and h,  respec- 
tively).  There was no consis- 
tent  difference  in the  spatial 
distribution  of B6-containing 
focal  contacts  between  cells 
expressing  full-length  t56  or 
777t from multiple  coverslips 
stained on two different occa- 
sions. No/~6 was seen in focal 
adhesions  for mock transfec- 
tants  and  cells  transfected 
with  the  truncation  770t  (e 
and g, respectively).  B6 also 
failed  to  localize  to  focal 
adhesions in cells  transfected 
with the truncations  738t and 
747t.  Length of the white bar 
in h represents  20 microns. 
able to spread normally on fibronectin in the presence of/$1 
blocking antibody (data not shown).  Similarly,  removal of 
the COOH-terminal  11 amino acids had no effect on local- 
ization of the receptor to focal contacts, but more extensive 
deletions  completely  abolished  focal  contact  localization 
(Fig. 5). This finding is consistent with our recent observa- 
tion  that  the  COOH-terminai  11  amino  acids  are  not  re- 
quired for localization of/$6 to focal contacts in CHO cells 
(Cone et al., 1994). These observations indicate that the por- 
tion of the/$6 cytoplasmic domain that is homologous to/$1 
and to/$3 is sufficient to support functions that are shared 
with/$1 and 153 integrins, i.e., localization to focal contacts 
and promotion of cell adhesion and spreading.  In contrast, 
a unique function of/$6- stimulation of cell proliferation- 
critically depends on the presence of the unique  11-amino 
acid extension. 
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Figure 6.  Quantitative effects 
of expression of full-length  or 
truncated 86 on adhesion of 
SW480  cells  to  fibronectin, 
vitronectin, and type I colla- 
gen.  (a)  SW480  cells trans- 
fected  with  pcDNAIneo, 
pcDNAIneo/~6,  or  pcDNAl- 
neo#6777t  were  allowed  to 
adhere  to individual wells of 
96-well microtiter plates which 
had been coated with a range 
of concentrations of fibronec- 
tin. 5  x  104 cells were seeded in the presence of E1 blocking antibody P5D2.  The same three cell lines, as well as cells transfected with 
pcDNAI-neo/~6770t were also allowed to attach to wells coated with a range of concentrations of type I collagen (b) or vitronectin (c). 
Non-adherent  cells were removed by centrifugation  and the attached cells stained with crystal violet (Weinacker et al., 1994). Cell adhesion 
was quantitated by measuring the absorbance at 595 nm in a Microplate Reader. The data shown represent mean (+ standard error) values 
from the nine data points obtained from triplicate wells in three separate experiments  in a and the three data points from triplicate wells 
in a single experiment in b and c. 
To obtain more quantitative information about the relative 
ability of SW480 cells transfected with intact or truncated 86 
cDNA to use 86 for attachment to fibronectin, we performed 
additional cell adhesion assays examining the attachment of 
pooled populations of SW480 cells transfected with pcDNAI- 
neo alone, with pcDNAIneo86 or with peDNAIneo86777t 
to a range of concentrations of fibronectin. Each of these as- 
says was performed on three separate occasions, and mean 
absorbance values were calculated from the nine data points 
obtained for each cell line at each concentration. As shown 
in Fig. 6 a, in the presence of 81-blocking antibody, cells ex- 
pressing full-length ~6 or 86777t bound equally well to all 
concentrations of fibronectin, whereas mock transfectants 
demonstrated little binding to any concentration. To deter- 
mine whether heterologous expression of intact or truncated 
86 altered the ability of SW480 cells to adhere to matrix pro- 
teins that are not ligands for etv86, we also performed cell 
adhesion assays to type I collagen and to vitronectin with the 
same populations of SW480 cells, and with cells transfected 
with pcDNAIneo770t. As shown in Fig. 6 (b and c), all three 
types of transfectants attached well to type I collagen and to 
vitronectin,  similar to the  results we have previously re- 
ported for SW480 cells transfected with pcDNAIneo and 
pcDNAIneo86 (Weinacker et al.,  1994). 
Effects of[36 Expression on the Proliferation of 
Embryonic Kidney Cells (293) in Collagen Gels 
We were uncertain whether the proliferative effect of 86 was 
specific to colon carcinoma cells. We therefore stably trans- 
fected  the  human  embryonic  kidney  cell  line  293  with 
pcDNAIneo or pcDNAIneo86, and selected one mock- and 
two  86-transfected clones  for further  study.  Mock-trans- 
fected  cells  do  not  express  detectable  amounts  of  86, 
whereas both 86-transfected clones express levels of  86 com- 
parable to those expressed by transfected SW480 cells (Fig. 
7 a). Both 86-transfected clones proliferated better in colla- 
gen gels than did the mock-transfected clone studied (Fig. 7 
b), suggesting that this effect of 86 is not specific for SW480 
cells, and can occur in non-tumor cells. 
In Vivo  Proliferation of  SW480 Cells in Nude Mice 
To determine whether expression of o~v86 would also in- 
crease the growth and/or spread of tumors formed by SW480 
cells in vivo, we stably transfected pools of mock-transfected 
SW480 cells and SW480 cells expressing either full-length 
or truncated 86 with a mammalian expression plasmid con- 
taining a full-length cDNA encoding the enzyme firefly lu- 
ciferase.  We then selected luciferase-transfected clones of 
a  Mock  #Z 
o 
lo  °  lo  ~  ~o  z 
#7 
MFI=507 
103  1(34  100  101  10  g  103  10'  103  10  ~  10  z  103  104 
Arbitrary fluorescence units 
b  tt~ 
O 
X 
¢0  n 
E  -I 
z 
(.3 
Mock  #2  #7 
136 transfected 
Figure  7.  Proliferation of mock and /$6-transfected 293  cells in 
three-dimensional collagen gels.  (a)  Fluorescence-activated  cell 
analysis histograms showing 86 expression  (detected  with mono- 
clonal antibody E7P6) in one mock and two 86 transfected 293 cell 
clones (#2 and #7.). Mean fluorescence  intensity (MFI) for each 
clone is  shown  above  each histogram.  (b)  Duplicate gels  were 
seeded with 104 cells for each of the transfectants  and the gels dis- 
solved seven days later with collagenase before estimating  cell num- 
ber in a bemocytometer.  Shaded bars are mean values of four data 
points from duplicate wells in two separate experiments,  and lines 
above each bar represent standard errors. 
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Figure 8. Growth of SW480 cell tumors in nude mice. Individual 
nude mice were injected with either 106 or 5  x  106 SW480 cells 
that had been stably transfected with a cDNA encoding firefly lu- 
ciferase  and  with  either  pcDNAIneo  alone  (mock),  or  with 
pcDNAIneo containing cDNA encoding either full-length B6 or/36 
truncated to eliminate the COOH-terminal  11  amino acids (/36 
7770. For each transfectant, three animals were injected with 106 
cells (harvested 9 wk later), and 3 with 5  x  106 cells (harvested 
6 wk later). The resultant tumors were completely excised from 
each of  the six mice in each group and the entire tumor was assayed 
for luciferase activity (expressed as arbitrary luminescence units). 
Each data point represents the value obtained from a single tumor 
in a single mouse. Bars shown to the right of each set of individual 
data points represent the mean +  standard error. 
each cell type that expressed equal amounts of luciferase ac- 
tivity per cell and injected either 106 or 5  x  10  ~ cells sub- 
cutaneously into the right flank of individual nude mice. 
Each type of cell was injected into six mice (three at  1@ 
cells/mouse and three at 5  ×  10  ~ cells/mouse) and the pri- 
mary tumors as well as liver, lung, heart, cecum, brain, and 
femur were removed either 6 (for animals injected with 5  x 
106 cells) or 9 wk (for animals injected with 10  ~ cells) later. 
The number of tumor cells at each site was quantified by 
measuring the luciferase activity in the homogenized tissue. 
This method was chosen to avoid the potentially confounding 
effects on tumor mass of in vivo differences in stroma forma- 
tion. Tumors formed by cells expressing full-length/36 con- 
sistently  contained  more  luciferase  activity  than  tumors 
formed by either mock-transfected ceils or cells expressing 
/36 that was  truncated to remove the  COOH-terminal  11 
amino acids (Fig. 8). None of the animals developed visible 
metastases at any site, and there was no detectable luciferase 
activity in any of the organs sampled except for the primary 
tumors. 
Discussion 
The results of the present study demonstrate that heterolo- 
gous expression of  the integrin c~v/36  augments cell prolifera- 
tion in three dimensional collagen gels, and in vivo in nude 
mice. In addition, these results show that a unique region of 
the cytoplasmic domain of the/36 subunit is required for this 
proliferative effect. Other functions of this integrin, includ- 
ing localization to focal contacts and mediation of stable cell 
adhesion, do not require this unique ll-amino acid COOH 
terminus, but rather are dependent on the 41-amino acid por- 
tion of the/36 cytoplasmic domain that is closely related to 
other/3 subunits such as/31 and/33. 
The observed effect of/36 expression on cell proliferation 
is biologically plausible given what is known about the pat- 
tern of expression of this subunit in normal and pathologic 
tissues. Using in situ hybridization with a/36-specific ribo- 
probe, we have shown that in healthy adult Rhesus monkeys, 
/36 mRNA has a quite narrow tissue distribution and is highly 
expressed only in the secretory uterine endometrium (Breuss 
et al., 1993). However,/36 is highly expressed in several epi- 
thelial tissues during embryonic development, after injury, 
and in malignant tumors, all conditions associated with in- 
creased proliferation (unpublished observations). 
A number of previous studies have demonstrated that the 
integrin  ot5/31 can  inhibit  tumor  growth  and  anchorage- 
independent proliferation. For example, overexpression of 
this integrin in CHO ceils markedly decreased the efficiency 
with which these cells formed colonies in soft agar, and de- 
creased the capacity of these cells to form tumors in nude 
mice (Giancotti and Ruoslahti,  1990).  In that study, cells 
overexpressing a5/31 also demonstrated enhanced ability to 
incorporate soluble fibronectin into a matrix, an effect the 
authors thought might contribute to decreased tumorigene- 
sis. The role of a5/31 in inhibiting cell proliferation was also 
demonstrated by studies in which the erythroleukemia cell 
line K562 was enriched for increased expression of ~5/31 by 
several  cycles  of positive  selection  through  adhesion  to 
fibronectin-coated dishes  (Symington,  1990).  K562  cells 
overexpressing ct5/31 differed from wild-type cells in their 
diminished capacity to form colonies in soft agar and in their 
failure to form tumors in nude mice. One possible explana- 
tion for the effect of ot5/31 on cell proliferation was suggested 
by a subsequent study by the same investigator demonstrat- 
ing that GRGDS peptide, an inhibitor of o~5/31, enhanced 
anchorage-independent growth  and  activated  two  cyclin- 
dependent kinases in K562 ceils selected for overexpression 
of ix5/31 (Symington, 1992). Additional evidence that ot5/31 
can inhibit tumorigenesis came from studies in which clones 
of CHO cells were selected for decreased levels of o~5/31 
(Schreiner et al.,  1991). In that study, t~5/31-deficient clones 
formed larger tumors in nude mice than did wild-type cells, 
and in vivo tumor growth was negatively correlated with the 
level of ct5/31 expression. 
The results of the present study appear to contrast with 
those described above, and suggest that the integrin av/36, 
which also recognizes fibronectin as a ligand, enhances cell 
proliferation and in vivo tumor growth. This effect occurs in 
three-dimensional collagen gels and in vivo in nude mice, 
but  not  in  collagen  or  fibronectin-coated tissue  culture 
dishes, suggesting that some aspect of a three-dimensional 
culture environment may be important for the proliferative 
effect observed. This effect cannot simply be ascribed to an 
effect on anchorage independence, since both wild-type and 
B6-transfected cells grow well in the absence of anchorage, 
as demonstrated by 100% efficiency in forming colonies in 
soft agar. This observation suggests that a three-dimensional 
culture environment and the presence of specific extracellu- 
lar matrix proteins (e.g., collagen) may be important for the 
proliferative effect seen. 
With regard to stimulation of tumor cell growth, several 
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tant role during the invasive growth phase of  malignant mela- 
noma (Albelda et al., 1990; Boukerche et al., 1989; Felding- 
Habermann et al., 1992). In one of these studies, melanoma 
cells lacking o~vB3 were shown to produce smaller tumors 
in  nude mice than their  otv/33(+)  counterparts  (Felding- 
Habermann et al.,  1992).  Recently, the  same  group has 
shown that melanoma cells lacking txvB3 undergo apoptosis 
in collagen gels in the absence of  growth factors, but are pro- 
tected from apoptosis by heterologous expression of av[33 
(Montgomery et al.,  1994).  In that study, the authors sug- 
gested that proteinases secreted by the melanoma cells were 
degrading the collagen, and revealing a cryptic RGD site that 
was then recognized by otv/33. It is conceivable that the cells 
we studied (SW480 and 293 cells) are also capable of secret- 
ing proteinases that degrade collagen, and that otv/36, which 
also recognizes the RGD site in fibronectin (Busk et al., 
1992),  is thus interacting directly with degraded collagen. 
However,  in contrast with transfected melanoma cells, we 
did not observe survival of transfected cells in collagen gels 
in the absence of serum (data not shown).  Furthermore, 
when we transfected SW480 cells with full-length B3 cDNA, 
expression of ctvB3 did not enhance the proliferation of these 
cells (data not shown). Finally, since/~3 does not contain the 
ll-amino acid sequence implicated in/36-dependent-growth 
regulation, it is likely that different mechanisms are involved 
in growth regulation by otvB6 and ave3. 
In the present study, subcutaneously injected SW480 cells 
expressing full-length B6 demonstrated an increased capac- 
ity to proliferate in vivo. Because this observation was made 
with a single tumor cell line in a small number of mice, we 
cannot determine whether txvB6 generally contributes to in 
vivo tumor growth. B6-transfected SW480 cells did not form 
detectable metastases within 6-9 wk. Furthermore, injec- 
tion of tumor cells directly into the spleen and implantation 
of tumor cells into the wall of the cecum did not produce 
significant numbers of metastases (data not shown). Thus, 
it will be necessary to examine the effects of/36 transfection 
on carcinoma cells with higher metastatic potential in order 
to determine the possible role of c~v/36 in tumor invasion, 
spread, or growth at metastatic sites. 
The results of the present study do not allow us to directly 
determine whether the  effects of/36 transfection on cell 
proliferation require the interaction of txv/36 with specific 
ligand(s).  Since  SW480  cells  themselves  secrete  large 
amounts of fibronectin, it was not possible to study the abil- 
ity of these cells to proliferate in the absence of ligand for 
o~vB6. Furthermore, fibronectin may not be the only ligand 
for this receptor.  Recent studies have suggested that o~vfl6 
may also be a receptor for the extracellular matrix protein 
tenascin (Prieto et al., 1993, and unpublished data). None- 
theless, the notion that otvB6-1igand interaction is required 
for enhanced proliferation is supported by our finding that 
the  blocking  anti-czv antibody,  L230,  abolished  the  B6- 
dependent increment in proliferation. Since the L230 anti- 
body is known to block o~vB6-mediated adhesion to fibro- 
nectin (Weinacker et al.,  1994),  it appears likely that this 
antibody inhibits proliferation by preventing czvB6-1igand 
interactions. Furthermore, we have recently constructed a 
mutant version of B6 that includes a single point mutation 
in an aspartic acid residue (Asp m) previously shown to be 
critical for interactions of/~1 and/33 integrins with ligands 
(Loftus et al.,  1990;  Takada et al.,  1992).  This mutant B6 
forms a heterodimer with w¢ that is well expressed on the 
cell surface, but is incapable of binding fibronectin (unpub- 
lished observations). SW480 cells expressing levels of this 
mutant receptor comparable to the levels of wild-type recep- 
tor in the B6-transfectants described in this manuscript do 
not demonstrate enhanced proliferation in collagen gels (un- 
published observation).  It thus appears  likely that ligand 
binding is important in the enhanced proliferation induced 
by B6. 
Our study implicates the COOH-terminal 11 amino acids 
of B6 in the generation of a  signal that leads to increased 
proliferation of colon carcinoma cells. This ll-amino acid 
sequence  is  not required  for B6-mediated adhesion,  cell 
spreading, or focal contact formation, suggesting that B6 en- 
hances growth by directly generating cytoplasmic signals, 
and not by altering anchorage or shape of the cells. The mo- 
lecular mechanisms underlying this effect remain to be eluci- 
dated. It is possible that the/36 COOH terminus directly in- 
teracts with a cytoplasmic signaling molecule. Alternatively, 
the/36 COOH terminus might modulate the function of an- 
other region of  the/36 cytoplasmic domain, or of  the otv cyto- 
plasmic domain, leading to altered signaling capacity. Fi- 
nally, it is possible that removing the COOH-terminal  11 
amino acids results in a  change in conformation in some 
other region of/36 that is itself responsible for induction of 
the  proliferative  response.  For  example,  removal  of the 
COOH-terminal 11 amino acids could lead to a change in the 
conformation of the remaining conserved region proximal to 
the  transmembrane  domain.  The  transfectants  we  have 
generated should be an ideal system to examine these possi- 
bilities and to identify the downstream events involved in 
augmentation of proliferation by the avB6 integrin. 
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